Skip to main navigation Skip to search Skip to main content

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

  • Hans-Christoph Diener
  • , Ralph L Sacco
  • , Salim Yusuf
  • , Daniel Cotton
  • , Stephanie Ounpuu
  • , William A Lawton
  • , Yuko Palesch
  • , Reneé H Martin
  • , Gregory W Albers
  • , Philip Bath
  • , Natan Bornstein
  • , Bernard P L Chan
  • , Sien-Tsong Chen
  • , Luis Cunha
  • , Björn Dahlöf
  • , Jacques De Keyser
  • , Geoffrey A Donnan
  • , Conrado Estol
  • , Philip Gorelick
  • , Vivian Gu
    • Karin Hermansson, Lutz Hilbrich, Markku Kaste, Chuanzhen Lu, Thomas Machnig, Prem Pais, Robin Roberts, Veronika Skvortsova, Philip Teal, Danilo Toni, Cam VanderMaelen, Thor Voigt, Michael Weber, Byung-Woo Yoon, Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group, Peter Passmore

Research output: Contribution to journal › Article › peer-review

318   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry